—
C+
C+ The full Closelook — membership. Open the C+ overview

Integra LifeSciences Holdings (IART) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — Integra LifeSciences Holdings

IART in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Integra LifeSciences makes medical devices for neurosurgery, ear-nose-throat care and wound treatment, sold through two divisions, Codman Specialty Surgical and Tissue Technologies. Codman covers tools for brain and spine surgery, such as monitoring equipment and dural repair products, plus surgical headlamps and instruments. Tissue Technologies covers skin substitutes and tissue repair materials used for burns, diabetic ulcers, hernia support and nerve repair. It sells to hospitals, surgery centres and clinicians in the United States and abroad, and is based in Princeton, New Jersey.
Where it sits in the stack
Integra LifeSciences holds no seat in Rubin, our AI build-out index; it sits in the Healthcare sector, within the medical-devices sleeve of our broader universe, and stops there.
Who it is priced against
Closelook's peer group for Integra LifeSciences is not yet defined; the comparison the market draws is with Medtronic, a broader medical-device maker active in similar surgical and neuro-technology markets.
Why Closelook tracks it
Integra LifeSciences holds a seat in the Russell 1000 but carries no Closelook score yet, and the diary has not quoted it in an edition to date.
What the diary watches
The diary watches how demand splits between the neurosurgery-focused Codman segment and the wound-care-focused Tissue Technologies segment as hospital capital spending shifts.

Integra LifeSciences Holdings (IART) trades on US exchanges.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for IART, from the same nightly bakes the boards use. Research diary readings, not advice.

Who it is priced against Medical Devices · United States · 8 names with week and year-to-date

Peer group

Medical Devices · United States

This name carries no Closelook score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against IART on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 55/100 · S&P 500 fund at 58, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-17
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 94th percentile of the window, +2.7% over 20 sessions. Factor regime → 2026-09-17
  • Sovereign pressure Index 0.00 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-17

FAQ · from the current data · as of 2026-09-18

Quick answers

What is Integra LifeSciences Holdings (IART)?

Integra LifeSciences Holdings trades as IART on the US exchange (United States) in the Closelook research universe, as of the registry build of 2026-09-18.

Is IART in a Closelook index?

Not currently — Integra LifeSciences Holdings is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-18.

Where does IART trade against its moving averages?

Pullback inside an uptrend stack: Trades -13.5% vs the 50-day and +8.4% vs the 200-day average, 26.3% below the 52-week high and +73.6% off the 52-week low; a golden cross printed 70 sessions ago. Computed from daily closes. As of 2026-09-17 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does Integra LifeSciences Holdings do?

Integra LifeSciences makes medical devices for neurosurgery, ear-nose-throat care and wound treatment, sold through two divisions, Codman Specialty Surgical and Tissue Technologies. Codman covers tools for brain and spine surgery, such as monitoring equipment and dural repair products, plus surgical headlamps and instruments. Tissue Technologies covers skin substitutes and tissue repair materials used for burns, diabetic ulcers, hernia support and nerve repair. Closelook's peer group for Integra LifeSciences is not yet defined; the comparison the market draws is with Medtronic, a broader medical-device maker active in similar surgical and neuro-technology markets.

Where does Integra LifeSciences Holdings sit in the AI build-out?

Integra LifeSciences holds no seat in Rubin, our AI build-out index; it sits in the Healthcare sector, within the medical-devices sleeve of our broader universe, and stops there. Integra LifeSciences holds a seat in the Russell 1000 but carries no Closelook score yet, and the diary has not quoted it in an edition to date.

What does this page show?

A live price chart with SMA overlays and drawing tools for IART, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe

then Medical Devices. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.